Md Anderson and TOPPAN Holdings Announce Strategic Alliance to Co-Develop Organoid Technology for Evaluating Cancer Treatments
Summary by Newswise
1 Articles
1 Articles
Md Anderson and TOPPAN Holdings Announce Strategic Alliance to Co-Develop Organoid Technology for Evaluating Cancer Treatments
MD Anderson and TOPPAN Holdings announced a strategic alliance to co-develop TOPPAN Holdings' invivoid 3D cell culture technology as a tool for personalized cancer treatments and drug screening efforts.
·Charlottesville, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium